Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Real Steps to Combat Racial Disparities in Diabetes Care |
|
| 2 | Black Patients With T1D and COVID-19 Face Added Risk of Diabetic Ketoacidos |
|
| 3 | T1D Exchange Quality Improvement Collaborative (QIC) Reaches 25 Diabetes Centers Participating Nationwide |
|
| 4 | Preliminary Findings of T1D Exchange's Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes Published in Diabetes Care |
|
| 5 | T1D Exchange Announces Population Health Surveillance Study of COVID-19 in Individuals with Type 1 Diabetes |
|
| 6 | T1D Exchange to Present Ten Studies Focused on Quality Improvement, Population Health and Real-World Evidence in Type 1 Diabetes at 80th American Diabetes Association Scientific Sessions |
|
| 7 | Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update |
|
| 8 | Odds for DKA higher for Black patients with type 1 diabetes, COVID-19 |
|
| 9 | Hospitalization Risk Four Times Higher in Blacks With T1D, COVID-19 |
|
| 10 | Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting |
|
| 11 | Boston-based study blazing trail on COVID-19 connection to diabetes |
|
| 12 | Emerging Data on Type 1 Diabetes and COVID-19 Reassuring |
|
| 13 | T1D Exchange Launches Online Registry to Drive Type 1 Diabetes Research |
|
| 14 | T1D Exchange Launches One-Stop Resource for the Type 1 Diabetes Community |
|
| 15 | New T1D Exchange CEO David Walton Talks Diabetes Research in 2020 |
|
| 16 | Black Americans With T1D, COVID-19 Have Increased Risk of Hospitalization for DKA |
|
| 17 | Black COVID-19 Patients See Quadrupled Risk of Diabetic Ketoacidosis |
|
| 18 | T1D Exchange Names David Walton as CEO |
|
| 19 | Tidepool Loop App for Diabetes Nears FDA Approval |
|
| 20 | T1D Exchange Co-Founder Dana Ball to Step Down as CEO |
|
| 21 | Organizations coming together to represent Type 1 diabetics during coronavirus |
|
| 22 | T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes |
|
| 23 | People with Type 1 diabetes may be at high risk for severe illness related to coronavirus: Study |
|
| 24 | CGM Use in T1D: Don't Count Older Patients Out |
|
| 25 | [Full text] Understanding the Profiles of Blood Glucose Monitoring Among Patients | PPA |
|
| 26 | Black Patients 4 Times More Likely to Develop Diabetic Ketoacidosis as White Patients |
|
| 27 | Point of View: Why aren't people with Type 1 diabetes getting vaccinated? |
|
| 28 | Parental Knowledge of Type 1 Diabetes Risk Appears to Lower Ketoacidosis Risk |
|
| 29 | Study reveals racial-ethnic inequities among people with type 1 diabetes and COVID-19 |
|
| 30 | Prioritize COVID-19 Vaccination in Both Types of Diabetes, Say Docs |
|
| 31 | Diabetes, COVID-19 combo riskier for minority groups, study shows |
|
| 32 | Advanced diabetes technology poised to play larger role in care, management |
|
| 33 | Deciding to Use an Insulin Pump or Not? |
|
| 34 | 'Should My Kid With T1D Go Back to School?' |
|
| 35 | Hyperglycemia common in T1DM patients with COVID-19 |
|
| 36 | Endocrinologist & Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange |
|
| 37 | Study looks at type I diabetes and COVID-19 |
|
| 38 | T1D Exchange Invests in Breakthrough Startup Admetsys to Improve Diabetes Care During Hospitalization |
|
| 39 | Race and Diabetes: Are Minorities Getting the Care They Deserve? |
|
| 40 | Diabetes Social Media Highlights for June 2020 |
|
| 41 | Dissecting Insulin Price Policy and Misinformation |
|
| 42 | Type 1 Diabetes Often Misdiagnosed in Adults and Children |
|
| 43 | Finalists Announced for 2018 Diabetes Innovation Challenge |
|
| 44 | Experts debate CV benefit of type 2 diabetes drugs for adults with type 1 |
|
| 45 | 2020 DiabetesMine D-Data ExChange Goes Virtual |
|
| 46 | A New Home Testing Kit Screens for Type 1 Diabetes |
|
| 47 | Type 1 Diabetes Misdiagnosed in One-Fourth of Children, Adults |
|
| 48 | Access to Healthcare Through Languages: Latinos and Type 1 Diabetes |
|
| 49 | Study shows how COVID-19 infection influences blood sugar in type 1 diabetes |
|
| 50 | Severe hypoglycemia, diabetic ketoacidosis twice as prevalent among adults with diabetic peripheral neuropathy |
|
| 51 | Cooling vests help COVID-19 nurses tolerate PPE; Diabetes adds to COVID-19 risks for Black patients |
|
| 52 | Recommendations for people with diabetes during COVID-19 |
|
| 53 | When and How to Take Antidepressants with Type 1 Diabetes |
|
| 54 | Tips for Managing Type 1 Diabetes Postpartum |
|
| 55 | New Diabetes Kids' Book on Spotting Low Blood Sugars |
|
| 56 | Societal Determinants of Health Drive Serious Diabetes Complications |
|
| 57 | The beginning of the end for Type 1 diabetes: A new view from immunotherapy science |
|
| 58 | Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (T1D) |
|
| 59 | Gut bacteria tied to disease severity, immune response; high mental health toll seen in ICUs |
|
| 60 | New IQVIA, JDRF Platform Will Use Real-World Data to Address T1D Diagnosis Gaps |
|
| 61 | Lockdown Bonus: Tighter Glucose Control in Type 1 Diabetes |
|
| 62 | Study Highlights Persistent Racial Disparities in Insulin Pump Use Among Children With T1D |
|
| 63 | Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression |
|
| 64 | Data Highlight Potential Insulin Cost Cap Savings for Pediatric T1D Population |
|
| 65 | Health Care After COVID: Racial Disparities Laid Bare |
|
| 66 | Does Gut Microbiome Composition Play a Role in T1D Pathogenesis? |
|
| 67 | International research consortium launched to improve obesity treatment |
|
| 68 | Filling prescriptions becomes easier for some, harder for others during COVID-19 |
|
| 69 | CORRECTING and REPLACING – Protomer Technologies Takes Top Prize in 2018 Diabetes Innovation Challenge |
|
| 70 | Prevalence of Comorbid Autoimmune Diseases, T1D in Children |
|
| 71 | CymaBay Announces Study to Evaluate the Potential for GPR119 Agonists to Prevent Hypoglycemia in Type 1 Diabetes |
|
| 72 | FDA rejects lower-dose empagliflozin 2.5 mg for type 1 diabetes |
|
| 73 | Closed-Loop Systems vs Sensor-Augmented Pumps in the Pediatric T1D Population |
|
| 74 | Study: Teplizumab Delays Progression to Type 1 Diabetes by 3 Years in High-risk Patients |
|
| 75 | Rethinking Type 1 diabetes with a radically new immunotherapy approach |
|
| 76 | Top Diabetes Social Media Posts of December 2020 |
|
| 77 | Plant-Based Diets High in Carbohydrates Found to Improve Type 1 Diabetes |
|
| 78 | Cannabis Use Doubles Risk for Ketoacidosis in Type 1 Diabetes |
|
| 79 | Examining Changes in BMI From Childhood to Puberty in Type 1 Diabetes |
|
| 80 | Moderate cannabis use increases risk for diabetic ketoacidosis among adults with type 1 diabetes |
|
| 81 | What's Up with Hydroxychloroquine and Diabetes? |
|
| 82 | Forecasting Diabetes Policy Priorities for 2021 |
|
| 83 | Provention Bio Announces US FDA Filing of a Biologics License Application (BLA) and Priority Review for Teplizumab for the Delay or Prevention of Clinical Type 1 Diabetes in At-risk Individuals |
|
| 84 | Study Finds No Evidence Linking Rotavirus Vaccine, T1D in Children |
|
| 85 | Bacterial Infections Linked to Coronary Heart Disease in Patients With Type 1 Diabetes |
|
| 86 | New FDA Clearance Paves The Way to Optimization of Insulin Pump Therapy Across All Glucose Measurement Methods |
|
| 87 | Diabetes Technology is Better, So Why are Outcomes Worse? |
|
| 88 | Provention Bio's Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients |
|
| 89 | Management of Type 1 Diabetes With a Very Low–Carbohydrate Diet |
|
| 90 | 2019 Round Up Part 2: A Look at The Year’s Most Notable Diabetes Collaborations |
|
| 91 | Pediatric Diabetes Complications Linked to Worse Memory, IQ |
|
| 92 | COVID-19, type 1 diabetes, and technology: why paediatric patients are leading the way |
|
| 93 | Medicare Expanding CGM Coverage for Diabetes |
|
| 94 | As obesity rate rises, 'double diabetes' looms large |
|
| 95 | Hoping for a Return to 'Normal' |
|
| 96 | 'A Bad Result': A1c Targets Missed in Most With Type 1 Diabetes |
|
| 97 | Three Practical New T1 Diabetes Apps for Kids and Parents |
|
| 98 | Childhood type 1 diabetes risk unaffected by autism |
|
| 99 | Forendo Pharma Appoints Dr Cristina Csimma as Chair of the Board of Directors |
|
| 100 | Covid-19: people with type 1 diabetes more likely to die than those with type 2 |
|